期刊文献+

CMVE-PEG3启动子在前列腺癌DU145细胞中的活性鉴定

Detection of Transcriptional Activities of PEG-3 Promoter Modified by CMV Enhancer in Human Prostate Cancer DU145 Cells
原文传递
导出
摘要 [目的]比较CMVE-PEG3p、PEG-3启动子在DU145细胞中的启动活性,为前列腺癌靶向性基因治疗提供依据。[方法]用PCR法扩增CMV增强子、PEG-3启动子;在真核表达质粒pShuttle-EGFP基础上分别构建2种启动子调控的、以绿色荧光蛋白为目的基因的真核表达质粒pShuttle-CMVE-PEG3p-EGFP、pShuttle-PEG3p-EGFP。将重组质粒用脂质体分别转染前列腺癌DU145细胞和人正常前列腺上皮细胞RWPE-1,72h后用Imagepro-Plus6.0分析2种启动子在相同时间内启动绿色荧光蛋白的表达水平。[结果]重组质粒在DU145细胞中观察到了绿色荧光,在RWPE-1细胞中无绿色荧光。pShuttle-CMVE-PEG3p-EGFP质粒在DU145细胞中表达强于pShuttle-PEG3p-EGFP,2种质粒在DU145细胞中的荧光强度(IOD)分别为246.22、130.93。[结论]所克隆的CMVE-PEG3p启动子和PEG-3启动子在前列腺癌DU145细胞中均表现出肿瘤特异性,其中CMVE-PEG3p启动子具有更强的启动效应,有望开发成为前列腺癌靶向性基因治疗的工具。 [Purpose] To compare the transcriptional activities of tumor-specific CMVE-PEG3 promoter and PEG-3 promoter in human prostate cancer DU145 cells,to provide base for targeting gene therapy in human prostate cancer.[Methods] The fragment of CMVE-PEG3 promoter and PEG-3 promoter were amplified by PCR.The eukaryotic expression plasmids (pShuttle-CMVE-PEG3p-EGFP and pShuttle-PEG3p-EGFP)which have enhanced green fluorescence protein reporter gene and modulated by CMVE-PEG3 promoter and PEG-3 promoter respectively were constructed based on the pShuttle-EGFP.These recombinant plasmids were transfected into DU145 and RWPE-1 cells with liposome.After 72 hours, the expression level of green fluorescent target protein modulated by 2 promoters at the same time was analyzed by Imagepro-Plus6.0 software.[Results] The green fluorescent target protein was observed in transfected DU145 cells,but there was no green fluorescence in transfected RWPE-1 control cells.The pShuttle-CMVE-PEG3p-EGFP had higher expression activity than pShuttle-PEG3p-EGFP in DU145 cells and the strength rate (IOD) of green fluorescence of DU145 cells transfected by pShuttle-CMVE-PEG3p-EGFP and pShuttle-PEG3p-EGFP were 246.22 and 130.93 respectively.[Conclusion] Our data reveals that the cloned CMVE-PEG3 and PEG-3 promoter are tumor-specific,and the CMVE-PEG3 promoter has higher transcriptional activities in prostate cancer DU145 cells,and may serve as a useful tool for transcriptional targeting gene therapy of human prostate cancer.
出处 《肿瘤学杂志》 CAS 2013年第7期548-552,共5页 Journal of Chinese Oncology
基金 国家自然科学基金资助项目(30800275)
关键词 CMV增强子 PEG-3基因 启动子 DU145细胞 基因治疗 CMV enhancer PEG-3 promoter DU145 cells gene therapy
  • 相关文献

参考文献15

  • 1Emdad L,Sarkar D,Su ZZ,et al. Progression elevatedgene-3 (PEG-3) induces pleiotropic effects on tumor pro-gression: modulation of genomic stability and invasionfj]. JCell Physiol,2005,202(1):135-146. 被引量:1
  • 2Sarkar S, Azab BM, Das SK,et al. Chemoprevention genetherapy (CGT): novel combinatorial approach for preventingand treating pancreatic cancer [J]. Curr Mol Med , 2012.[Epub ahead of print]. 被引量:1
  • 3Greco A,Di Benedetto A,Howard CM,et al. Eradicationof therapy-resistant human prostate tumors using an ultra-sound-guided site-specific cancer terminator virus deliveryapproach[J]. Mol Ther,2010,18(2):295-306. 被引量:1
  • 4Sarkar D,Lebedeva IV,Su ZZ,et al. Eradication of thera-py-resistant human prostate tumors using a cancer termi-nator virus[J]. Cancer Res, 2007,67(11):5434-5442. 被引量:1
  • 5Emdad L,Sarkar D,Lebedeva IV,et al. Ionizing radiationenhances adenoviral vector expressing mda-7/IL-24-mediatedapoptosis in human ovarian cancer[J]. J Cell Physiol ,2006,208(2):298-306. 被引量:1
  • 6Jiang XL,Du LL,Yang S,et al. Suppression of teratocar-cinoma growth by soluble TRAIL gene expression drivenby the progression-elevated gene-3 promoter[J]. Cancer BiolTher,2009,8(15):1517-1524. 被引量:1
  • 7Van Maerken T,Sarkar D,Speleman F,et al. Adenovirus-mediated hPNPase (old-35) gene transfer as a therapeuticstrategy for neuroblastomafj]. J Cell Physiol, 2009,219(3):707-715. 被引量:1
  • 8Bhang HE,Gabrielson KL,Laterra J,et al. Tumor-specificimaging through progression elevated gene-3 promoter-driven gene expression[J]. Nat Med, 2011,17(1):123-129. 被引量:1
  • 9Sarkar D,Su ZZ, Park ES,et al. A cancer terminator viruseradicates both primary and distant human melanomas [J].Cancer Gene Ther,2008,15(5):293-302. 被引量:1
  • 10Das SK,Sarkar S,Dash R,et al. Chapter One-Cancer ter-minator viruses and approaches for enhancing therapeuticoutcomes[J]. Adv Cancer Res,2012,115:1-38. 被引量:1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部